NCT00407667

Brief Summary

Transcranial galvanic stimulation (tDCS) seems to promote motor recovery after stroke by stimulating (anodal) or inhibiting (cathodal) neural circuits in the brain. In the treatment of severe arm paresis after stroke, robot-assisted arm training (AT) proved to be effective, but nevertheless only a few patients could use their affected hand functionally in daily life after robot training. Therefore the present study intends to combine both approaches, tDCS + AT, applied at the same time every day for six weeks. The study has three treatment arms, two groups will receive the tDCS, either anodal of the lesioned or cathodal of the non-lesioned hemisphere. The anodal stimulation is expected to facilitate the activity of the arm motor area of the lesioned side directly, while the cathodal stimulation of the non-lesioned hemisphere is expected to facilitate the lesioned side indirectly by decreasing inhibitory inputs. The third group will receive a sham-stimulation. All patients will work with the AT simultaneously to the tDCS, respectively sham-tDCS.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P75+ for not_applicable stroke

Timeline
Completed

Started Dec 2006

Typical duration for not_applicable stroke

Geographic Reach
2 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 1, 2006

Completed
Same day until next milestone

Study Start

First participant enrolled

December 1, 2006

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 5, 2006

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2009

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2009

Completed
Last Updated

March 21, 2011

Status Verified

November 1, 2006

Enrollment Period

2.7 years

First QC Date

December 1, 2006

Last Update Submit

March 18, 2011

Conditions

Keywords

hemiparesisrehabilitationupper limb rehabilitationarm therapy

Outcome Measures

Primary Outcomes (1)

  • Fugl-Meyer Upper Limb Motor Score (0-66)

    45 min

Secondary Outcomes (1)

  • Box&Block Test

    5 min

Study Arms (3)

1

EXPERIMENTAL

patients receive 20 min of anodal transcranial stimulation plus 20 min of repetitive arm training with a therapy robot(Bi-Manu-Track)

Device: transcranial galvanic stimulation

2

EXPERIMENTAL

patients receive 20 min of cathodal transcranial stimulation plus 20 min of repetitive arm training with a therapy robot(Bi-Manu-Track)

Device: transcranial galvanic stimulation

3

SHAM COMPARATOR

patients receive 20 min of sham transcranial stimulation plus 20 min of repetitive arm training with a therapy robot(Bi-Manu-Track)

Device: transcranial galvanic stimulation

Interventions

for tDCS: Siemens Universal-Neuroton 826 for arm training: Bi-Manu-Track, Reha-Stim, Berlin

123

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • subacute stroke
  • stroke interval 3 to 8 weeks
  • severe upper limb paresis
  • Fugl-Meyer \< 18

You may not qualify if:

  • history of epilepsy
  • antiepileptic, neuroleptic medication
  • metal implants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Charité, University Medicine Berlin, Medical Park Berlin

Berlin, 13507, Germany

Location

Klinik Bavaria

Kreischa, 09567, Germany

Location

Villa Melitta

Bolzano, 3600, Italy

Location

MeSH Terms

Conditions

StrokeParesis

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Stefan Hesse, MD

    Charité -University Medicine Berlin; Medical Park Berlin

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 1, 2006

First Posted

December 5, 2006

Study Start

December 1, 2006

Primary Completion

August 1, 2009

Study Completion

December 1, 2009

Last Updated

March 21, 2011

Record last verified: 2006-11

Locations